This Article Abstract Full Text Full Text (PDF) View Online Appendix Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alfonso, F. Search for Related Content PubMed PubMed Citation Articles by Alfonso, F.

Long-Term Results (Three to Five Years) of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Stenting (RIBS) Randomized Study

Fernando Alfonso, MD^_*,_*, José M. Augé, MD^,, Javier Zueco, MD, Armando Bethencourt, MD, José R. López-Mínguez, MD^||, José M. Hernández, MD^¶, Juan A. Bullones, MD^#, Isabel Calvo, MD^**, Enrique Esplugas, MD, María J. Pérez-Vizcayno, MD^_*, Raul Moreno, MD^_*, Cristina Fernández, MD^_*, Rosana Hernández, MD^_*, Vasco Gama-Ribeiro, MD for the RIBS Investigators

^_* Clinico San Carlos, Madrid, Spain
Santa Cruz y San Pablo, Barcelona, Spain
Marqués de Valdecilla, Santander, Spain
Son Dureta, Palma de Mallorca, Spain
^|| Infanta-Cristina, Badajoz, Spain
^¶ Virgen de la Victoria, Malaga, Spain
^# Carlos Haya, Malaga, Spain
^** Miguel Servet, Zaragoza, Spain
Bellvitge, Barcelona, Spain
Vila Nova de Gaia, Porto, Portugal
Deceased

View larger version (28K): [in a new window]   Figure 1 Event-free survival (EFS) at four years. (A) Freedom from death, myocardial infarction, and target vessel revascularization. (B) Freedom from "cardiac" death, myocardial infarction, and target vessel revascularization. (C) Freedom from "cardiac" death or myocardial infarction. (D) Freedom from target vessel revascularization.

View larger version (20K): [in a new window]   Figure 2 Clinical events according to the 10 prespecified variables. B/A = balloon-to-artery ratio; CI = confidence interval; LAD = left anterior descending coronary artery; RE = restenosis.

View larger version (18K): [in a new window]   Figure 3 Event-free survival (EFS) (death, myocardial infarction, target vessel revascularization) in patients with large vessels according to treatment allocation.